Regulus Therapeutics News
Most Popular Regulus Therapeutics Story
Analysts predict next biotech IPOs
After a two-year IPO drought, Cumberland Pharma ended the biotech dry spell earlier this year when it launched a successful IPO. Since then, six companies have pulled off what once seemed to be an Read more...
Latest Headlines
- April 14, 2011
- June 22, 2010
- February 25, 2010
- November 24, 2009
- October 7, 2009
- March 4, 2009
- June 23, 2008
- April 17, 2008
- February 13, 2008
- December 4, 2007
- September 7, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
